- li>
- li>
- li>
- li>
- li>
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | -0.00 | -0.60 | -99.50 |
| EPS, GAAP | -0.19 | -0.61 | -0.61 |
| Consensus Estimate | -0.15 | -0.52 | -71.89 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 0.70 | 1.67 | -58.01 |
| EPS, GAAP | 0.64 | 1.59 | -59.98 |
| Consensus Estimate | 0.59 | 1.49 | -60.34 |
| EBS | Industry Average | |
| P/E (TTM) | 13.20 | NA |
| P/E (Forward) | 21.08 | NA |
| PEG Ratio | 0.53 | 2.17 |
| Price/Sales | 1.64 | 4.18 |
| Beta | 0.73 | 0.62 |
| 3/12/2012 | Sharing is caring, and PharmAthene shareholders couldn't be happier. (The Motley Fool) |
| 3/12/2012 | Finding companies that have all the right stuff can produce winners. (The Motley Fool) |
| 3/9/2012 | Updates, advisories and surprises (MarketWatch.com) |
| 3/6/2012 | Do these fallen angels deserve a second chance? You be the judge! (The Motley Fool) |
![[sm061210things]](http://s.wsj.net/public/resources/images/PF-AC562_sm0612_C_20120514113337.jpg)
![[sm0612wedding4]](http://s.wsj.net/public/resources/images/PF-AC579_sm0612_C_20120515172853.jpg)
![[sm0612strat]](http://s.wsj.net/public/resources/images/PF-AC580_sm0612_C_20120515180019.jpg)
![[sm0612roi]](http://s.wsj.net/public/resources/images/PF-AC573_sm0612_C_20120515125902.jpg)